Name: adjuvant chemotherapy of breast cancer: papers presented at the 2nd international conference on adjuvant chemotherapy of breast cancer, kantonsspital
Price: 112.37 EUR
Availability: InStock
Author: Senn, Hans-Jörg
ISBN: 9783642823596

portada adjuvant chemotherapy of breast cancer: papers presented at the 2nd international conference on adjuvant chemotherapy of breast cancer, kantonsspital

adjuvant chemotherapy of breast cancer: papers presented at the 2nd international conference on adjuvant chemotherapy of breast cancer, kantonsspital

Type

Physical Book

Illustrated by

Hans-Jörg Senn

Publisher

Springer

Author

Senn, Hans-Jörg

Year

2011

Language

English

Pages

246

Format

Paperback

Dimensions

24.4 x 17.0 x 1.4 cm

Weight

0.43 kg.

ISBN

3642823599

ISBN13

9783642823596

Synopsis "adjuvant chemotherapy of breast cancer: papers presented at the 2nd international conference on adjuvant chemotherapy of breast cancer, kantonsspital"

H.-J. Senn Adjuvant Chemotherapy (ACT) of breast cancer has now emerged as one of the controversial su): >jects in clinical and also experimental oncology. Driven by growing frustration about stagnating cure rates in breast cancer [1,4] and stimulated by elegant demonstration of highly curative effects of adjuvant systemic therapy in animal models [6, 11] and in several childhood neoplasias [15], researchers introduced ACT to the primary treatment of breast cancer with great hope some 15 years ago. After a first wave of isolated "historic" trials with generally limited but in one case remarkable success [5, 9], a second generation of ACT studies was initiated by NSABP investigators and oncology centers in Europe [2, 6, 13]. These trials were well conducted statistically and diagnostically, and all in the early 1970s included a surgical control arm. Early and intermediate beneficial effects on relapse-free survival (RFS) after 2-3 years median observation time then prompted a whole series of ACT studies in breast cancer. These "third-gener- ation" studies usually regarded some positive influence of ACT as a given fact, dropping surgical control regimens and comparing different ACT regimens, hopefully in a prospective, randomized way 1984 Fig. 1. The mushrooming of adjuvant studies in breast cancer XII Introduction [reviews in 3, 14]. The "mushrooming" of ACT studies in breast cancer during the last 10 and especially 5 years is demonstrated in Fig. 1, and it gets really cumbersome even for the insider to keep on top of the multitude of sometimes conflicting data.

Customers reviews

Have you read this book? Login to add your review.

More customer reviews

0% (0)
0% (0)
0% (0)
0% (0)
0% (0)

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews

adjuvant chemotherapy of breast cancer: papers presented at the 2nd international conference on adjuvant chemotherapy of breast cancer, kantonsspital - Senn, Hans-Jörg

Synopsis "adjuvant chemotherapy of breast cancer: papers presented at the 2nd international conference on adjuvant chemotherapy of breast cancer, kantonsspital"

Customers reviews

Frequently Asked Questions about the Book

Is the book original?

In what language is the book written?

What is the format of this book?

Questions and Answers about the Book

Opinions about Bookdelivery